The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C

被引：14
作者：
Adinolfi, Luigi Elio [1 ]
Rinaldi, Luca [1 ]
Marrone, Aldo [1 ]
Giordano, Mauro [1 ]
机构：
[1] Univ Campania L Vanvitelli, Dept Med Surg Neurol Metab & Geriatr Sci, Naples, Italy
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2018年 / 16卷 / 08期
关键词：
DAAs; chronic hepatitis C; insulin resistance; type 2 diabetes mellitus; GLYCEMIC CONTROL; IMPROVEMENT; INFECTION; HCV;
D O I：
10.1080/14787210.2018.1505500
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：595 / 597
页数：3
相关论文
共 15 条
  • [1] Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients
    Adinolfi, Luigi E.
    Nevola, Riccardo
    Guerrera, Barbara
    D'Alterio, Giovanni
    Marrone, Aldo
    Giordano, Mauro
    Rinaldi, Luca
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (07) : 1379 - 1382
  • [2] Metabolic alterations and chronic hepatitis C: treatment strategies
    Adinolfi, Luigi E.
    Restivo, Luciano
    Zampino, Rosa
    Lonardo, Amedeo
    Loria, Paola
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (14) : 2215 - 2234
  • [3] Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience
    Alem, Shereen Abdel
    Elsharkawy, Aisha
    Fouad, Rabab
    Adel, Eman
    Abdellatif, Zeinab
    Musa, Sherief
    Nagy, Ahmed
    Hussein, Muhammad S.
    Yosry, Ayman
    Esmat, Gamal
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (12) : 2181 - 2187
  • [4] Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes
    Aytug, S
    Reich, D
    Sapiro, LE
    Bernstein, D
    Begum, N
    [J]. HEPATOLOGY, 2003, 38 (06) : 1384 - 1392
  • [5] Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents
    Ciancio, Alessia
    Bosio, Roberta
    Bo, Simona
    Pellegrini, Marianna
    Sacco, Marco
    Vogliotti, Edoardo
    Fassio, Giulia
    Degerfeld, Andrea G. F. Bianco Mauthe
    Gallo, Monica
    Giordanino, Chiara
    di Bergamo, Lodovico Terzi
    Ribaldone, Davide
    Bugianesi, Elisabetta
    Smedile, Antonina
    Rizzetto, Mario
    Saracco, Giorgio Maria
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (02) : 320 - 327
  • [6] Dawood AA, 2017, DIABETES METAB J, V41, P316
  • [7] HCV and diabetes: towards a 'sustained' glycaemic improvement after treatment with DAAs?
    Fabrizio, C.
    Procopio, A.
    Scudeller, L.
    Dell'Acqua, R.
    Bruno, G.
    Milano, E.
    Milella, M.
    Saracino, A.
    Angarano, G.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (05) : 342 - 343
  • [8] Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus
    Hum, Justine
    Jou, Janice H.
    Green, Pamela K.
    Berry, Kristin
    Lundblad, James
    Hettinger, Barbara D.
    Chang, Michael
    Ioannou, George N.
    [J]. DIABETES CARE, 2017, 40 (09) : 1173 - 1180
  • [9] Li J, 2017, HEPATOLOGY, V66, p531A
  • [10] Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo, Amedeo
    Adinolfi, Luigi Elio
    Petta, Salvatore
    Craxi, Antonio
    Loria, Paola
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (03) : 293 - 308
12